Skip to content

DIASCAN Blood Glucose Self-Monitoring Test Strips

by Home Diagnostics, Inc.

510(k) K872505

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK872505 Date20 Oct 1987ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
CGA
Device Class
Class II
Regulation
21 CFR Part 862.1345
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 27 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

The device is supplied as test strips for self-monitoring of blood glucose. It is authorized under FDA 510(k) clearance K872505, classified as a Class II medical device under regulation number 862.1345, and manufactured by Home Diagnostics, Inc.

Other devices from Home Diagnostics, Inc.

See all devices from Home Diagnostics, Inc. →

Questions

AI-generated answers, 27 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the DIASCAN* Blood Glucose Self-Monitoring Test Strip used for?

    The DIASCAN* Blood Glucose Self-Monitoring Test Strip is intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, idiopathic hypoglycemia, and pancreatic islet cell carcinoma.

  • How is the DIASCAN* Blood Glucose Self-Monitoring Test Strip supplied?

    The device is supplied as test strips for self-monitoring of blood glucose, designed for use by individuals outside of clinical settings to monitor their glucose levels.

  • Is the DIASCAN* Blood Glucose Self-Monitoring Test Strip a single-use or reusable device?

    The DIASCAN* Blood Glucose Self-Monitoring Test Strip is intended for single-use only, as each strip is designed to be used once per glucose measurement to ensure accuracy and prevent contamination.

  • What regulatory pathway was used for the DIASCAN* Blood Glucose Self-Monitoring Test Strip?

    The DIASCAN* Blood Glucose Self-Monitoring Test Strip received FDA 510(k) clearance under submission K872505, demonstrating substantial equivalence to a legally marketed predicate device.

  • What class of medical device is the DIASCAN* Blood Glucose Self-Monitoring Test Strip?

    The DIASCAN* Blood Glucose Self-Monitoring Test Strip is classified as a Class II medical device under regulation number 862.1345, as indicated in its FDA 510(k) clearance documentation.